- Frost & Sullivan to Host Quarterly Analyst Briefing on Thursday, 26 February 2009
—
LONDON, February 17LONDON, February 17 /PRNewswire/ -- The Chemicals Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on Medical Trends Impacting the Chemicals and Materials Market to be held on Thursday, 26 February, 2009 at 3 p.m. GMT.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
Medical applications represent a strong market amidst the current challenging economic climate. There are growth opportunities for companies across the value chain for products such as medical devices, packaging and drug controlled release technologies.
The Frost & Sullivan analyst briefing will look at the key competitive issues together with current legislative frameworks and how they are impacting chemicals and materials suppliers.
Taking part in this briefing will benefit any chemicals or materials company supplying the healthcare industry such as polymer manufacturers and pharmaceutical excipient manufacturers by discussing emerging trends and providing forward projections for the global industry.
"Traditionally, complex legislative frameworks have deterred companies from entering the market but this is now fast changing," observe Industry Analysts Hariharan Ramasubramanian and Leonidas Dokos. Furthermore, according to Dr. Keith Schlagbauer, Director of Consulting for Healthcare at Frost & Sullivan, "Chemicals and materials companies have a critical role to play in the future development of healthcare products."
Frost & Sullivan will hold this conference call at 3 p.m. GMT on Thursday, 26 February, 2009, which will provide industry participants an outlook on Medical Trends impacting the Chemicals and Materials Markets. To participate, please email Katja Feick at katja.feick@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you.
Frost & Sullivan has expanded its flagship Global Congress on Corporate Growth - GIL Global - into several major cities around the world including London. For the first time ever in Europe, Frost & Sullivan will be hosting the Growth, Innovation and Leadership Congress 'GIL 2009: Europe' on 19-20 May, at the Sofitel St James in London. GIL Global is the industry's only event designed to support senior executives in their efforts to achieve sustainable, top-line growth. To register, obtain a programme agenda, explore sponsorship opportunities, or attend as a member of the media for GIL 2009: Europe, please contact Katja Feick, Corporate Communications Europe, at katja.feick@frost.com. One-on-One interviews with Frost & Sullivan senior growth consultants are also being scheduled. For more information you can also visit www.frost.com/giluk
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com./
Contact: Katja Feick Corporate Communications - Europe P: +49(0)69-77-0-33-43 F: +49(0)69-23-45-66 E: katja.feick@frost.com http://www.frost.com/
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
